Key result
Ischemic heart disease and diabetes associate with elevated protein C antigen unlike other thrombotic conditions.
Why the study?
Are Protein C antigen levels elevated in patients with conditions associated with thromboembolism, and does it act as an acute-phase reactant?
Observational (n=299)
Are Protein C antigen levels elevated in patients with conditions associated with thromboembolism, and does it act as an acute-phase reactant?
Protein C antigen levels are specifically elevated in ischemic heart disease and diabetes, and this elevation is not a non-specific acute-phase reaction to inflammation or tissue injury.
Protein C antigen elevation should not yet guide thromboembolism management; leaves open its role as a selective biomarker in ischemic heart disease and diabetes.
Protein C, an antithrombotic protein, was measured immunologically in 299 patients with clinical conditions associated with a high frequency of venous or arterial thromboembolism. The mean protein C antigen (PC:Ag) level was high for 48 patients with ischemic heart disease and, to a lesser extent, for 95 diabetics. In 28 patients with thrombotic strokes, 48 patients with proximal deep-vein thrombosis and in 80 patients with localized or metastatic tumors, mean PC:Ag was normal. Comparison of the pattern of changes of PC:Ag levels with those of fibrinogen, orosomucoid and prothrombin in 21 patients during the postoperative period and in 20 patients with active rheumatoid arthritis ruled out the possibility that high PC:Ag is non-specific, acute-phase reaction to inflammation, tissue injury or neoplastic growth. Therefore, high PC:Ag might be specifically related to the thrombotic tendency of these patients, but the mechanism of such a relationship remains to be clarified.
No takes yet. Share an insight, caveat, or question.
Viganò et al. (1984) conducted an observational in Clinical conditions associated with a high frequency of venous or arterial thromboembolism (n=299). Ischemic heart disease and diabetes vs. Thrombotic strokes, proximal deep-vein thrombosis, and localized or metastatic tumors was evaluated on Protein C antigen (PC:Ag) level. Mean protein C antigen levels were high in patients with ischemic heart disease and diabetes, but normal in those with thrombotic strokes, deep-vein thrombosis, or tumors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: